Table 2. Phase IIb programme STAIR II criteria.
• Route of administration |
• Dose range |
• Time from stroke onset to initiation of treatment |
• Pharmacokinetic profile |
• Side effects and their frequency |
• Drug interactions |
• Drug distribution to the proposed site of action |
• Refinement and identification of the target population |
• Established therapeutic activity through evaluation of clinical and/or surrogate markers |